Announcing partnership with CityFALCON. Read more (Published: 2017-02-13)

ESPR - Esperion Therapeutics Mon 27'th Feb 2017

Industry: Biotechnology Sector: Healthcare
Add to Watchlist

Strong Buy Candidate

Score: 5.48

#541 of 5165
Trend:
MV Long:
MV Short:
Pivot:
Volume:
MACD:
Score:
Accuracy: 87.81%
Risk: High
Request Prediction
We need your help. Please answer this short survey to help us improve by clicking HERE.

Stock analysis for Mon 27'th Feb 2017 (Updated daily)

Buy candidate since 2017-02-27

Esperion Therapeutics Stock Analysis


Esperion Therapeutics gained 6.50% in the last trading day, rising from USD 24.29 to USD 25.87. The price has risen in 6 of the last 10 days days and is up by 23.07% over the past 2 weeks. Volume also increased in the last day along with the price, which is a positive technical sign, and, in total, 0.34 million more shares were traded than the day before. In total, 1.01 million shares bought and sold for approximately USD 26.10 million.

Trend

Esperion Therapeutics has broken the very wide and strong rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at USD 24.85, a level that may pose a second chance to hit a runner. According to fan-theory USD 35.03 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.

Signals

Only positive signals in the chart today. Esperion Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at USD 24.24 and USD 16.50. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday February 13, 2017, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Relative Strength Index (RSI)

The stock holds a RSI14 at 76 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Support & Resistance

Esperion Therapeutics finds support from accumulated volume at USD 25.00, USD 24.37, and USD 20.14. There is no resistance from accumulated volume above today's level and given the right condition the stock may perform very well during the next couple of days.

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 2.70 between high and low, or 11.34%. For the last week, the stock has had a daily average volatility of 13.59%.

The stock is extremely overbought on RSI14 (76). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stoploss: USD 25.69 (-0.70%) ( Criterias: risk and break of trend)

Evaluation

Several short-term signals, are positive and the stock has broken the rising trend up, which indicates even stronger rising rate. We conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Strong Buy Candidate.

Strong Buy Candidate


Want to start trading like a professional?

Access Portfolios Now!

Want to be one step ahead of others?

Subscribe Now!

Click for pro features list

Chart Explanation

Build Your Watchlist

Add ESPR My Watchlist

Weekly Trading Secrets

Recommended
book of the week

Sign up to get FREE access to all of our features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

Get rid of this notification!

Sign up / Log in
5165
Companies analyzed today